About
Abyrx is a privately held company founded in 2013, based in Irvington, NY. The company specializes in developing and manufacturing advanced biomaterials and therapeutic devices for surgical procedures. Abyrx focuses on innovative materials science platforms tailored to various surgical applications and holds over 50 issued and pending patents for its product technologies. The core product line of Abyrx includes hemostatic bone putties designed to stop bone bleeding during surgery. Their offerings feature a water-soluble hemostatic bone putty in syringe-like applicators for ease of use, a settable, resorbable bone putty that adheres to bleeding bone surfaces, and MONTAGE, a flagship product that is cohesive, settable, and resorbable. Abyrx's products cater to multiple surgical specialties, including orthopedic, trauma, spine, sports medicine, cranial and maxillofacial, and cardiothoracic surgery. The company also develops applicator devices to enhance the delivery of these biomaterials during procedures.
Technologies
Keywords
Company Information
-
Employees 16
-
Founded 2005
-
Annual Revenue $20574000
-
Total Funding $35000000
Location
700 Fairfield Ave, Stamford, Connecticut, United States, 06902-7526